Project | The control group (mean ± SD) | Experimental group (mean ± SD) | t/Z | P |
---|---|---|---|---|
N = 40 | N = 40 | |||
age | 74.63 ± 8.10 | 74.80 ± 9.02 | 0.091 | 0.928 |
Gender (male) | 23 (57.50%) | 27 (67.50%) | 0.853 | 0.356 |
Heart rate (b/min) | 93.95 ± 18.73 | 99.93 ± 20.18 | 1.372 | 0.174 |
SBP (mmHg) | 119.25 ± 33.40 | 115.45 ± 23.58 | 0.588 | 0.558 |
DBP (mmHg) | 73.80 ± 20.80 | 71.10 ± 16.38 | 0.645 | 0.521 |
Breathing (breaths/min) | 18.50 (17.00, 21.00) | 19.50 (18.00, 25.00) | 2.091 | 0.037 |
Temperature (℃) | 37.05 (36.70,37.70) | 37.10 (36.68, 38.10) | 0.554 | 0.580 |
APACHE-II | 21.75 ± 3.69 | 22.10 ± 3.87 | 0.414 | 0.680 |
SOFA | 13.00 (11.00, 14.75) | 13.00 (11.00, 17.00) | 0.73 | 0.465 |
GCS | 11.00 (8.00, 12.00) | 11.00 (8.00, 13.00) | 0.222 | 0.824 |
Past history, n (%) | ||||
COPD | 3 (7.50) | 5 (12.50) | 0.556 | 0.456 |
Heart failure | 3 (7.50) | 5 (12.50) | 0.556 | 0.456 |
Gastrointestinal illness | 4 (10.00) | 4 (10.00) | 0.000 | 1.000 |
Chronic kidney disease | 3 (7.50) | 3(7.50) | 0.000 | 1.000 |
Chronic liver disease | 0 (0.00) | 3 (7.50) | 3.117 | 0.077 |
Cerebrovascular accident | 9 (22.50) | 5 (12.50) | 1.385 | 0.239 |
diabetes | 23 (57.50) | 22 (55.00) | 0.051 | 0.822 |
Coronary heart disease | 20 (50.00) | 15 (37.50) | 1.270 | 0.260 |
hypertension | 22 (55.00) | 15 (37.50) | 2.464 | 0.116 |